| Thu, Dec 17, 2009 | | • | Anadys hepatitis C drug meets key study goals
AP (Thu, Dec 17)
| | Wed, Dec 16, 2009 | | • | Achillion shares rise on hepatitis C drug data
AP (Wed, Dec 16)
| | Thu, Dec 3, 2009 | | • | PHARMASSET INC Financials
EDGAR Online Financials (Thu, Dec 3)
| | Tue, Dec 1, 2009 | | • | PHARMASSET INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Tue, Dec 1)
| | Thu, Nov 26, 2009 | | • | New Star Analyst Rankings for Pharmasset, Inc.
StarMine (Thu, Nov 26)
| | Wed, Nov 25, 2009 | | • | Pharmasset Reports Fiscal Year End 2009 Financial Results
PR Newswire (Wed, Nov 25)
| | • | PHARMASSET INC Files SEC form 10-K, Annual Report
EDGAR Online (Wed, Nov 25)
| | Mon, Nov 23, 2009 | | • | Pharmasset: hepatitis C drug trial will continue
AP (Mon, Nov 23)
| | • | Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
PR Newswire (Mon, Nov 23)
| | Tue, Nov 17, 2009 | | • | Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
at TheStreet.com (Tue, Nov 17)
| | • | InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
at TheStreet.com (Tue, Nov 17)
| | Mon, Nov 9, 2009 | | • | Pharmasset to Present at Lazard Capital Markets Healthcare Conference
PR Newswire (Mon, Nov 9)
| | • | Doc Offers Top Hep C Drug Picks: BioBuzz
at TheStreet.com (Mon, Nov 9)
| | Tue, Nov 3, 2009 | | • | INFORM-1 Results: Robust Antiviral Suppression Achieved with Combination of Nucleoside Analog Polymerase Inhibitor RG7128 and Protease Inhibitor RG7227
PR Newswire (Tue, Nov 3)
| | Sun, Nov 1, 2009 | | • | Pharmasset to Webcast an Investor Event from the AASLD Meeting
PR Newswire (Sun, Nov 1)
| | Mon, Aug 10, 2009 | | • | PHARMASSET INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Aug 10)
| | Tue, Aug 4, 2009 | | • | PHARMASSET INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Aug 4)
| | Wed, Jun 17, 2009 | | • | PHARMASSET INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Wed, Jun 17)
| | Thu, May 14, 2009 | | • | PHARMASSET INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, May 14)
| | Mon, May 11, 2009 | | • | PHARMASSET INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 11)
|
Add VRUS News to My Yahoo!:
 
| |
|
0.11% Nasdaq 
0.01%
Headlines
